The United States Pharmacopeial (USP) Guidelines have identified specific testing requirements that must occur with compounded preparations. These guidelines, which are based in science, were established to ensure patient care and safety. These are not just guidelines. This is the right thing to do. Do you know WHAT to test? Do you know WHEN to test it? Do you know WHY you are testing it?
Join Eagle Analytical Services Chief Technical Officer, Dr. Ross Caputo, for this free Webinar. During this time we will share the testing requirements for your compounding facility. We will also help you to navigate the “what, when & the why’s” of testing.
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Antimicrobial Effectiveness | USP 795 & 797 Revisions - July 18, 2023
- 2023 PDA/FDA Joint Regulatory Conference, 09/18 – 09/20 - July 11, 2023
- APC: Compounders on Capitol Hill, 09/19 – 09/20 - July 11, 2023
